Ilumetri 100 mg solution for injection in pre-filled syringe
*Company:
Almirall LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 15 July 2024
File name
ie-SmPC-Ilumetri 100 mg-LTSE.pdf
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 10 July 2024
File name
ie-uk-pl-ilumetri-100mg-pfs.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
PIL updated with polysorbate warning plus typographical corrections.
Updated on 10 July 2024
File name
ie-SmPC-Ilumetri 100 mg-LTSE.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Update to section 4.4 - polysorbate warning, 4.8 - addition of long term safety information with section on immunogenicity, 5.1 - update of reSURFACE 1 and reSURFACE 2 findings, 6.1 E433 number added for Polysorbate 80, 10 - updated date of revision 07 May 2024
Almirall Limited
Address:
Harman House, 1 George Street, Uxbridge, Middlesex, UB8 1QQ, UKMedical Information E-mail:
Almirall@EU.ProPharmaGroup.comTelephone:
+44 (0) 207 160 2500Website:
https://www.almirall.co.ukMedical Information Direct Line:
014319836